Brief: Aytu Biopharma - Board,Management Decided Some Of Co's Previously Issued Interim Unaudited Consolidated Financial Statements Should No Longer Be Relied Upon
Feb 21 (Reuters) - Aytu Biopharma Inc AYTU.O :
* AYTU BIOPHARMA - BOARD,MANAGEMENT DECIDED SOME OF CO'S
PREVIOUSLY ISSUED INTERIM UNAUDITED CONSOLIDATED FINANCIAL
STATEMENTS SHOULD NO LONGER BE RELIED UPON
* AYTU BIOPHARMA - CO'S INTERIM UNAUDITED CONSOLIDATED
FINANCIAL
STATEMENTS AS OF AND FOR QUARTER ENDED SEPT 30, 2022 SHOULD NO
LONGER BE RELIED UPON
Further company coverage: AYTU.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations